Individualized medicine enabled by genomics in Saudi Arabia
详细信息 查看全文
- 作者：Muhammad Abu-Elmagd (10) (7) (8) (9)
Mourad Assidi (7) (8)
Hans-Juergen Schulten (7)
Ashraf Dallol (7) (8)
Peter Natesan Pushparaj (7)
Farid Ahmed (7)
Stephen W Scherer (11) (12) (7)
Mohammed Al-Qahtani (7)
10. Zoology Department ; Faculty of Science ; Minia University ; Minia ; P.O. Box 61519 ; Egypt
7. Centre of Excellence in Genomic Medicine Research (CEGMR) ; King Abdulaziz University ; P.O. Box ; 80216 ; Jeddah ; 21589 ; KSA
8. KACST Technology Innovation Centre in Personalized Medicine at King Abdulaziz University (CIPM) ; P.O. Box ; 80216 ; Jeddah ; 21589 ; KSA
9. School of Biological Sciences ; University of East Anglia ; Norwich ; Norfolk ; NR4 7TJ ; UK
11. The Centre for Applied Genomics and Program in Genetics and Genome Biology ; the Hospital for Sick Children ; Toronto ; Ontario ; Canada
12. McLaughlin Centre and Department of Molecular Genetics ; University of Toronto ; Toronto ; Ontario ; Canada - 刊名：BMC Medical Genomics
- 出版年：2015
- 出版时间：December 2015
- 年：2015
- 卷：8
- 期：1-supp
- 全文大小：996 KB
- 参考文献：1. Tadmouri, GO, Al Ali, MT, Al-Haj Ali, S, Al Khaja, N (2006) CTGA: the database for genetic disorders in Arab populations. Nucleic acids research 34: pp. D602-606
2. plus-plus">Qatar Biobank for Medical Research. [p://www.qatarbiobank.org.qa/" class="a-plus-plus">http://www.qatarbiobank.org.qa/]
3. plus-plus">Saudi Human Genome Program. [p://rc.kfshrc.edu.sa/sgp/" class="a-plus-plus">http://rc.kfshrc.edu.sa/sgp/]
4. Tadmouri, GO, Nair, P, Obeid, T, Al Ali, MT, Al Khaja, N, Hamamy, HA (2009) Consanguinity and reproductive health among Arabs. Reproductive health 6: pp. 17
5. Memish, ZA, Saeedi, MY (2011) Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and beta-thalassemia in Saudi Arabia. Annals of Saudi medicine 31: pp. 229-235
6. Ng, SW, Zaghloul, S, Ali, HI, Harrison, G, Popkin, BM (2011) The prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf States. Obesity reviews : an official journal of the International Association for the Study of Obesity 12: pp. 1-13
7. Fortina, P, Khaja, NA, Ali, MT, Hamzeh, AR, Nair, P, Innocenti, F, Patrinos, GP, Kricka, LJ (2014) Genomics into healthcare: the 5th pan arab human genetics conference and 2013 golden helix symposium. Human mutation 35: pp. 637-640
8. Scherer, SW (2012) Genomics is the medium for 21st century biology. Genome / National Research Council Canada = Genome / Conseil national de recherches Canada 55: pp. v
9. Sheridan, E, Wright, J, Small, N, Corry, PC, Oddie, S, Whibley, C, Petherick, ES, Malik, T, Pawson, N, McKinney, PA (2013) Risk factors for congenital anomaly in a multiethnic birth cohort: an analysis of the Born in Bradford study. Lancet 382: pp. 1350-1359
10. Fida, NM, Al-Aama, J, Nichols, W, Nichols, W, Alqahtani, M (2007) A prospective study of congenital malformations among live born neonates at a University Hospital in Western Saudi Arabia. Saudi medical journal 28: pp. 1367-1373
11. Becker, SM, Al Halees, Z, Molina, C, Paterson, RM (2001) Consanguinity and congenital heart disease in Saudi Arabia. American journal of medical genetics 99: pp. 8-13
12. El Mouzan, MI, Al Salloum, AA, Al Herbish, AS, Qurachi, MM, Al Omar, AA (2008) Consanguinity and major genetic disorders in Saudi children: a community-based cross-sectional study. Annals of Saudi medicine 28: pp. 169-173
13. Al Bu Ali, WH, Balaha, MH, Al Moghannum, MS, Hashim, I (2011) Risk factors and birth prevalence of birth defects and inborn errors of metabolism in Al Ahsa, Saudi Arabia. The Pan African medical journal 8: pp. 14
14. Shoukri MM, Donner A, Dessouky NA, Subhani S, Al-Joufan M, Al-Omrani A, Al-Mohanna F, Al Halees ZY: plus-plus">Estimation of modified concordance ratio in sib-pairs: effect of consanguinity on the risk of congenital heart diseases. / The international journal of biostatistics 2010.,plus-plus">6(1)plus-plus">: Article 3
15. Al-Mesned, A, Al Akhfash, AA, Sayed, M (2012) Incidence of severe congenital heart disease at the province of Al-Qassim, Saudi Arabia. Congenital heart disease 7: pp. 277-282
16. Mitri, W, Sandridge, AL, Subhani, S, Greer, W (2002) Design and development of an Internet registry for congenital heart defects. Teratology 65: pp. 78-87
17. el-Hazmi, MA, al-Swailem, AR, Warsy, AS, al-Swailem, AM, Sulaimani, R, al-Meshari, AA (1995) Consanguinity among the Saudi Arabian population. Journal of medical genetics 32: pp. 623-626
18. Greer, W, Sandridge, AL, Al-Menieir, M, Al Rowais, A (2005) Geographical distribution of congenital heart defects in Saudi Arabia. Annals of Saudi medicine 25: pp. 63-69
19. al-Jurayyan, NA, Shaheen, FI, al-Nuaim, AA, el-Desouki, MI, Faiz, A, al Herbish, AS, Bakr, AM, al-Swailem, AA, al Mazrou, YY (1996) Congenital hypothyroidism: increased incidence in Najran province, Saudi Arabia. Journal of tropical pediatrics 42: pp. 348-351
20. Al-Jurayyan, NA, Al-Herbish, AS, El-Desouki, MI, Al-Nuaim, AA, Abo-Bakr, AM, Al-Husain, MA (1997) Congenital anomalies in infants with congenital hypothyroidism: is it a coincidental or an associated finding?. Human heredity 47: pp. 33-37
21. Al-Jurayyan, NA, Al-Nuaim, AA, Redha, MA, El-Desouki, MI, Al Herbish, AS, Abo Bakr, AM, Al Swailem, AA, Al Mazrou, YY, Al Deress, A (1996) Neonatal screening for congenital hypothyroidism in Riyadh: Analysis of six year's experience. Annals of Saudi medicine 16: pp. 20-23
22. Asindi, AA, Al-Daama, SA, Zayed, MS, Fatinni, YA (2002) Congenital malformation of the gastrointestinal tract in Aseer region, Saudi Arabia. Saudi medical journal 23: pp. 1078-1082
23. Asindi, A, Al-Shehri, A (2001) Neural tube defects in the Asir Region of Saudi Arabia. Annals of Saudi medicine 21: pp. 26-29
24. El-Awad Mel, H, Sivasankaran, S (1992) Neural tube defects in Southwestern region of Saudi Arabia. Annals of Saudi medicine 12: pp. 449-452
25. Bassuni, W, Abbag, F, Asindi, A, Al Barki, A, Al Binali, AM (1997) Neonatal deaths in the Asir Region of Saudi Arabia: Experience in a Referral Neonatal Intesive Care Unit. Annals of Saudi medicine 17: pp. 522-526
26. Alqurashi, M, El Mouzan, M, Al Herbish, A, Al Salloum, A, Al Omer, A (2007) Symptomatic congenital heart disease in the Saudi Children and Adolescents Project. Annals of Saudi medicine 27: pp. 442-444
27. Hakami, WS, Majeed-Saidan, MA (2011) The incidence and spectrum of central nervous system malformations in newborns over a decade (2001-2010) in the Central Region of Saudi Arabia. Saudi medical journal 32: pp. 1137-1142
28. Murshid, WR (2000) Spina bifida in Saudi Arabia: is consanguinity among the parents a risk factor?. Pediatr Neurosurg 32: pp. 10-12
29. Miao, CY, Zuberbuhler, JS, Zuberbuhler, JR (1988) Prevalence of congenital cardiac anomalies at high altitude. Journal of the American College of Cardiology 12: pp. 224-228
30. Herrera, R, Li Lora, JA, Ingalls, TH, Marticorena, E (1977) [Congenital malformations in the newborns at high altitude]. Archivos de biologia andina 7: pp. 94-101
31. Castilla, EE, Lopez-Camelo, JS, Campana, H (1999) Altitude as a risk factor for congenital anomalies. American journal of medical genetics 86: pp. 9-14
Prevalence of congenital anomalies at high altitude area in saudi arabia. Saudi medical journal 1: pp. 44-51
32. Al-Othaimeen, AI, Al-Nozha, M, Osman, AK (2007) Obesity: an emerging problem in Saudi Arabia. Analysis of data from the National Nutrition Survey. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 13: pp. 441-448
33. Balaha, MH, Ali, WH, Al Aswad, LH, Al Moghannum, MS, Hashim, I (2012) Maternal obesity predict isolated birth defects in live births in Eastern Province of Saudi Arabia. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet 25: pp. 924-929
34. Eyaid W, Al-Tassan RS, Al-Nouri DM: plus-plus">Intracranial calcifications, microcephaly, and seizure. If not congenital infection, what could it be? In / Neurosciences. / Volume 17. Riyadh, Saudi Arabia; 2012:248鈥?52.
35. El-Hazmi, MA (2004) The natural history and the national pre-marital screening program in Saudi Arabia. Saudi medical journal 25: pp. 1549-1554
36. Cannistraci, CV, Ogorevc, J, Zorc, M, Ravasi, T, Dovc, P, Kunej, T (2013) Pivotal role of the muscle-contraction pathway in cryptorchidism and evidence for genomic connections with cardiomyopathy pathways in RASopathies. BMC medical genomics 6: pp. 5
37. Al-Qattan, MM, Al-Thunayan, A, Alabdulkareem, I, Al Balwi, M (2013) Liebenberg syndrome is caused by a deletion upstream to the PITX1 gene resulting in transformation of the upper limbs to reflect lower limb characteristics. Gene 524: pp. 65-71
38. Al-Odaib, AN, Abu-Amero, KK, Ozand, PT, Al-Hellani, AM (2003) A new era for preventive genetic programs in the Arabian Peninsula. Saudi medical journal 24: pp. 1168-1175
39. Al-Odaib, A (2003) Saudi Newborn Screening (NBS) Program for Metabolic Diseases.
40. Zegers-Hochschild, F, Adamson, GD, de Mouzon, J, Ishihara, O, Mansour, R, Nygren, K, Sullivan, E, van der Poel, S (2009) The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Hum Reprod 24: pp. 2683-2687
41. Mundi, I (2013) Saudi Arabia Demographics Profile.
42. Boivin J, Bunting L, Collins JA, Nygren KG: plus-plus">International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. In / Human reproduction. / Volume 22. Oxford, England; 2007:1506鈥?512. 10.1093/humrep/dem046
Health topics: Infertility. World Health Organization.
43. Dyer, SJ (2009) International estimates on infertility prevalence and treatment seeking: potential need and demand for medical care. Hum Reprod 24: pp. 2379-2380
44. Buhling, KJ, Grajecki, D (2013) The effect of micronutrient supplements on female fertility. Current opinion in obstetrics & gynecology 25: pp. 173-180
45. Mascarenhas, MN, Flaxman, SR, Boerma, T, Vanderpoel, S, Stevens, GA (2012) National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS medicine 9: pp. e1001356
46. Liu, J, Wang, W, Sun, X, Liu, L, Jin, H, Li, M, Witz, C, Williams, D, Griffith, J, Skorupski, J (2012) DNA microarray reveals that high proportions of human blastocysts from women of advanced maternal age are aneuploid and mosaic. Biology of reproduction 87: pp. 148
47. Duncan, FE, Hornick, JE, Lampson, MA, Schultz, RM, Shea, LD, Woodruff, TK (2012) Chromosome cohesion decreases in human eggs with advanced maternal age. Aging cell 11: pp. 1121-1124
48. Desai, N, Sabanegh, E, Kim, T, Agarwal, A (2010) Free radical theory of aging: implications in male infertility. Urology 75: pp. 14-19
49. Okun, N, Sierra, S, Wilson, RD, Audibert, F, Brock, JA, Campagnolo, C, Carroll, J, Cartier, L, Chitayat, D, Gagnon, A (2014) Pregnancy outcomes after assisted human reproduction. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 36: pp. 64-83
50. Gerris, J (2009) Single-embryo transfer versus multiple-embryo transfer. Reproductive biomedicine online 18: pp. 63-70
51. Esteves, SC, Miyaoka, R, Agarwal, A (2011) Sperm retrieval techniques for assisted reproduction. International braz j urol : official journal of the Brazilian Society of Urology 37: pp. 570-583
52. Agarwal, A, Bragais, FM, Sabanegh, E (2008) Assessing sperm function. The Urologic clinics of North America 35: pp. 157-171
53. Mehri, S, Levi Setti, PE, Greco, K, Sakkas, D, Martinez, G, Patrizio, P (2014) Correlation between follicular diameters and flushing versus no flushing on oocyte maturity, fertilization rate and embryo quality. Journal of assisted reproduction and genetics 31: pp. 73-77
54. Assidi, M, Sirard, M-A Cumulus Cell Gene Expression as a Marker of Oocyte Quality. In:
55. Forman, EJ, Tao, X, Ferry, KM, Taylor, D, Treff, NR, Scott, RT (2012) Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates. Hum Reprod 27: pp. 1217-1222
56. Straughen, JK, Salihu, HM, Keith, L, Petrozzino, J, Jones, C (2013) Obligatory versus elective single embryo transfer in in vitro fertilization. A population-based analysis of data from the U.K. Human Fertilisation and Embryology Authority. The Journal of reproductive medicine 58: pp. 95-100
57. Hodes-Wertz, B, Grifo, J, Ghadir, S, Kaplan, B, Laskin, CA, Glassner, M, Munne, S (2012) Idiopathic recurrent miscarriage is caused mostly by aneuploid embryos. Fertility and sterility 98: pp. 675-680
58. Kochhar, PK, Ghosh, P (2013) Reproductive outcome of couples with recurrent miscarriage and balanced chromosomal abnormalities. The journal of obstetrics and gynaecology research 39: pp. 113-120
59. Lo Giacco, D, Chianese, C, Sanchez-Curbelo, J, Bassas, L, Ruiz, P, Rajmil, O, Sarquella, J, Vives, A, Ruiz-Castane, E, Oliva, R (2013) Clinical relevance of Y-linked CNV screening in male infertility: new insights based on the 8-year experience of a diagnostic genetic laboratory. European journal of human genetics : EJHG.
60. Ibrahim, NK, Bashawri, J, Al Bar, H, Al Ahmadi, J, Al Bar, A, Qadi, M, Milaat, W, Feda, H (2013) Premarital Screening and Genetic Counseling program: knowledge, attitude, and satisfaction of attendees of governmental outpatient clinics in Jeddah. Journal of infection and public health 6: pp. 41-54
61. Adashi, EY, Barri, PN, Berkowitz, R, Braude, P, Bryan, E, Carr, J, Cohen, J, Collins, J, Devroey, P, Frydman, R (2003) Infertility therapy-associated multiple pregnancies (births): an ongoing epidemic. Reproductive biomedicine online 7: pp. 515-542
62. Yuen, RK, Merkoulovitch, A, Macdonald, JR, Vlasschaert, M, Lo, K, Grober, E, Marshall, CR, Jarvi, KA, Kolomietz, E, Scherer, SW (2014) Development of a high-resolution Y-chromosome microarray for improved male infertility diagnosis. Fertility and sterility.
63. Nepomnyashchaya, YN, Artemov, AV, Roumiantsev, SA, Roumyantsev, AG, Zhavoronkov, A (2013) Non-invasive prenatal diagnostics of aneuploidy using next-generation DNA sequencing technologies, and clinical considerations. Clinical chemistry and laboratory medicine : CCLM / FESCC 51: pp. 1141-1154
64. Colls, P, Escudero, T, Fischer, J, Cekleniak, NA, Ben-Ozer, S, Meyer, B, Damien, M, Grifo, JA, Hershlag, A, Munne, S (2012) Validation of array comparative genome hybridization for diagnosis of translocations in preimplantation human embryos. Reproductive biomedicine online 24: pp. 621-629
65. Al-Hamdan, N, Ravichandran, K, Al-Sayyad, J, Al-Lawati, J, Khazal, Z, Al-Khateeb, F, Abdulwahab, A, Al-Asfour, A (2009) Incidence of cancer in Gulf Cooperation Council countries, 1998-2001. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 15: pp. 600-611
66. plus-plus">10-Year Cancer Incidence Among Nationals of the GCC States 1998鈥?007. [p://www.moh.gov.bh/pdf/publications/GCC%20Cancer%20Incidence%202011.pdf" class="a-plus-plus">http://www.moh.gov.bh/pdf/publications/GCC%20Cancer%20Incidence%202011.pdf]
67. plus-plus">World Health Organization, Regional Office for the Eastern Mediterranean, Cancer registration in the Region. [p://www.emro.who.int/noncommunicable-diseases/information-resources/cancer-registration.html" class="a-plus-plus">http://www.emro.who.int/noncommunicable-diseases/information-resources/cancer-registration.html]
68. plus-plus">Cancer Incidence Report in Saudi Arabia 2009. [p://scr.clearvision.com.sa/" class="a-plus-plus">http://scr.clearvision.com.sa/]
69. plus-plus">GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. [p://globocan.iarc.fr" class="a-plus-plus">http://globocan.iarc.fr]
70. Howlader N NA, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (Eds): plus-plus">SEER Cancer Statistics Review, 1975鈥?010 In / SEER web site. National Cancer Institute. Bethesda, MD; 2013. November 2012 SEER data submission
71. Al-Zahrani AS, Ravichandran K: plus-plus">Epidemiology of thyroid cancer: a review with special reference to Gulf Cooperation Council (GCC) states. / The Gulf journal of oncology 2007, (2)plus-plus">:17鈥?8.
72. Hussain, F, Iqbal, S, Mehmood, A, Bazarbashi, S, ElHassan, T, Chaudhri, N (2013) Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010. Hematology/oncology and stem cell therapy 6: pp. 58-64
73. Alghamidi, IG, Hussain, II, Alghamdi, MS, El-Sheemy, MA (2013) The incidence rate of prostate cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from the Saudi Cancer Registry 2001-2008. Hematology/oncology and stem cell therapy.
74. Elkum, N, Dermime, S, Ajarim, D, Al-Zahrani, A, Alsayed, A, Tulbah, A, Al Malik, O, Alshabanah, M, Ezzat, A, Al-Tweigeri, T (2007) Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC cancer 7: pp. 222
75. Chouchane, L, Boussen, H, Sastry, KS (2013) Breast cancer in Arab populations: molecular characteristics and disease management implications. The lancet oncology 14: pp. e417-424
76. Alanazi, M, Pathan, AA, Arifeen, Z, Shaik, JP, Alabdulkarim, HA, Semlali, A, Bazzi, MD, Parine, NR (2013) Association between PARP-1 V762A Polymorphism and Breast Cancer Susceptibility in Saudi Population. PloS one 8: pp. e85541
77. Siraj, AK, Al-Rasheed, M, Ibrahim, M, Siddiqui, K, Al-Dayel, F, Al-Sanea, O, Uddin, S, Al-Kuraya, K (2008) RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. Journal of endocrinological investigation 31: pp. 893-899
78. Siraj, AK, Ibrahim, M, Al-Rasheed, M, Abubaker, J, Bu, R, Siddiqui, SU, Al-Dayel, F, Al-Sanea, O, Al-Nuaim, A, Uddin, S (2008) Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. BMC medical genetics 9: pp. 61
79. Al-Qasem, A, Toulimat, M, Tulbah, A, Elkum, N, Al-Tweigeri, T, Aboussekhra, A (2012) The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi women. Oncology letters 3: pp. 875-878
80. Al-Sudairy, R, Al-Nasser, A, Alsultan, A, Al Ahmari, A, Abosoudah, I, Al-Hayek, R, Al-Harbi, T, Al-Manjomi, F, Al-Harbi, M, Al-Ghamdi, H (2014) Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia in Saudi Arabia: a multi-institutional retrospective national collaborative study. Pediatric blood & cancer 61: pp. 74-80
81. Uddin, S, Hussain, A, Ahmed, M, Belgaumi, A, Al-Dayel, F, Ajarim, D, Bavi, P, Al-Kuraya, KS (2008) S-phase kinase protein 2 is an attractive therapeutic target in a subset of diffuse large B-cell lymphoma. The Journal of pathology 216: pp. 483-494
82. AlShemmari SH, Ameen RM, Sajnani KP: plus-plus">Extranodal lymphoma: a comparative study. In / Hematology. / Volume 13. Amsterdam, Netherlands; 2008:163鈥?69. 10.1179/102453308X316149
83. Temmim, L, Baker, H, Amanguno, H, Madda, JP, Sinowatz, F (2004) Clinicopathological features of extranodal lymphomas: Kuwait experience. Oncology 67: pp. 382-389
84. Hussain, AR, Uddin, S, Ahmed, M, Al-Dayel, F, Bavi, PP, Al-Kuraya, KS (2013) Phosphorylated IkappaBalpha predicts poor prognosis in activated B-cell lymphoma and its inhibition with thymoquinone induces apoptosis via ROS release. PloS one 8: pp. e60540
85. Hussain, AR, Uddin, S, Ahmed, M, Bu, R, Ahmed, SO, Abubaker, J, Sultana, M, Ajarim, D, Al-Dayel, F, Bavi, PP (2010) Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling. The Journal of pathology 222: pp. 180-190
86. Uddin, S, Hussain, AR, Ahmed, M, Siddiqui, K, Al-Dayel, F, Bavi, P, Al-Kuraya, KS (2012) Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma. Haematologica 97: pp. 1092-1100
87. Uddin, S, Hussain, AR, Ahmed, M, Bu, R, Ahmed, SO, Ajarim, D, Al-Dayel, F, Bavi, P, Al-Kuraya, KS (2010) Inhibition of fatty acid synthase suppresses c-Met receptor kinase and induces apoptosis in diffuse large B-cell lymphoma. Molecular cancer therapeutics 9: pp. 1244-1255
88. Khan, F, Ruterbusch, JJ, Gomez, SL, Schwartz, K (2013) Differences in the cancer burden among foreign-born and US-born Arab Americans living in metropolitan Detroit. Cancer causes & control : CCC 24: pp. 1955-1961
89. Siegel, R, Naishadham, D, Jemal, A (2013) Cancer statistics. CA: A Cancer J Clinicians 63: pp. 11-30
90. Mehmood, A, Te, OB, Urcia, JC, Khan, A (2011) Tumor Registry Annual Report. King Faisal Specialist Hospital & Research Center, Kingdom of Saudi Arabia
91. plus-plus">CancerStats. [p://www.cancerresearchuk.org/cancer-info/cancerstats/" class="a-plus-plus">http://www.cancerresearchuk.org/cancer-info/cancerstats/]
92. Al-Qutub, ST, Al-Raddadi, RM, Bin Sadiq, BM, Sait, W, Al-Gahmi, A, Al-Amoudi, S (2013) Potential breast cancer risk factors among Saudi women aged 19-50 years in Jeddah: a case-control study. The Journal of the Egyptian Public Health Association 88: pp. 165-170
93. plus-plus">PINK Indian Statistics. [p://www.breastcancerindia.net/bc/statistics/stati.htm" class="a-plus-plus">http://www.breastcancerindia.net/bc/statistics/stati.htm]
94. El-Harith el, HA, Abdel-Hadi, MS, Steinmann, D, Dork, T (2002) BRCA1 and BRCA2 mutations in breast cancer patients from Saudi Arabia. Saudi medical journal 23: pp. 700-704
95. Hasan, TN, Shafi, G, Syed, NA, Alsaif, MA, Alsaif, AA, Alshatwi, AA (2013) Lack of association of BRCA1 and BRCA2 variants with breast cancer in an ethnic population of Saudi Arabia, an emerging high-risk area. Asian Pacific journal of cancer prevention : APJCP 14: pp. 5671-5674
96. Hussein, S, Merdad, A, Al-Maghrabi, J, Gari, M, Al-Thubaiti, F, Hussein, I, Chaudhary, A, Abuzenadah, A, Tashkandi, H, Al-Khayyat, S (2014) Detection of rare single nucleotide variants affecting genes in the DNA repair pathways in hereditary breast cancer. BMC Genomics 15: pp. P20
97. plus-plus">Saudi Human Genome Program. [p://rc.kfshrc.edu.sa/sgp/" class="a-plus-plus">http://rc.kfshrc.edu.sa/sgp/]
98. Jia, Y, Lu, Y, Wu, K, Lin, Q, Shen, W, Zhu, M, Huang, S, Chen, J (2013) Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studies. Cancer epidemiology 37: pp. 197-206
99. Kelleher, FC, Rao, A, Maguire, A (2014) Circadian molecular clocks and cancer. Cancer letters 342: pp. 9-18
100. Zelinski, EL, Deibel, SH, McDonald, RJ (2014) The trouble with circadian clock dysfunction: Multiple deleterious effects on the brain and body. Neuroscience and biobehavioral reviews 40c: pp. 80-101
101. Massart, R, Freyburger, M, Suderman, M, Paquet, J, El Helou, J, Belanger-Nelson, E, Rachalski, A, Koumar, OC, Carrier, J, Szyf, M (2014) The genome-wide landscape of DNA methylation and hydroxymethylation in response to sleep deprivation impacts on synaptic plasticity genes. Translational psychiatry 4: pp. e347
102. Korkmaz, A, Sanchez-Barcelo, EJ, Tan, DX, Reiter, RJ (2009) Role of melatonin in the epigenetic regulation of breast cancer. Breast cancer research and treatment 115: pp. 13-27
103. Shylu Mathew AM, Jaudah Al-Maghrabi, Ashraf Dallol: plus-plus">Identification of frequent MTNR1B methylation in breast cancer following the application of high-throughput methylome analysis. / BMC Genomics 2014.,plus-plus">15(Supplement 2)plus-plus">:
104. Al-Daghri, NM, Khan, N, Alkharfy, KM, Al-Attas, OS, Alokail, MS, Alfawaz, HA, Alothman, A, Vanhoutte, PM (2013) Selected dietary nutrients and the prevalence of metabolic syndrome in adult males and females in Saudi Arabia: a pilot study. Nutrients 5: pp. 4587-4604
105. Buhmeida, A, Dallol, A, Merdad, A, Al-Maghrabi, J, Gari, MA, Abu-Elmagd, MM, Chaudhary, AG, Abuzenadah, AM, Nedjadi, T, Ermiah, E (2013) High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
106. Dutra RL, de Carvalho MB, dos Santos M, Mercante AC, Gazito D, de Cicco R, Group G, Tajara EH, Louro ID, da Silva AMA: plus-plus">FGFR4 Profile as a Prognostic Marker in Squamous Cell Carcinoma of the Mouth and Oropharynx. / PloS one 2012.,plus-plus">7(11)plus-plus">:
107. Zaid, TM, Yeung, TL, Thompson, MS, Leung, CS, Harding, T, Co, NN, Schmandt, RS, Kwan, SY, Rodriguez-Aguay, C, Lopez-Berestein, G (2013) Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage High-Grade Serous Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 19: pp. 809-820
108. Luo, Y, Yang, C, Lu, W, Xie, R, Jin, C, Huang, P, Wang, F, McKeehan, WL (2010) Metabolic Regulator ?Klotho Interacts with Fibroblast Growth Factor Receptor 4 (FGFR4) to Induce Apoptosis and Inhibit Tumor Cell Proliferation*. The Journal of Biological Chemistry 285: pp. 30069-30078
109. Poh, W, Wong, W, Ong, H, Aung, MO, Lim, SG, Chua, BT, Ho, HK (2012) Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma. Molecular Cancer 11: pp. 14
110. Dallol, A, Al-Maghrabi, J, Buhmeida, A, Gari, MA, Chaudhary, AG, Schulten, HJ, Abuzenadah, AM, Al-Ahwal, MS, Sibiany, A, Al-Qahtani, MH (2012) Methylation of the polycomb group target genes is a possible biomarker for favorable prognosis in colorectal cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 21: pp. 2069-2075
111. Buhmeida, A, Merdad, A, Al-Maghrabi, J, Al-Thobaiti, F, Ata, M, Bugis, A, Syrjanen, K, Abuzenadah, A, Chaudhary, A, Gari, M (2011) RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency. Anticancer research 31: pp. 2975-2981
112. Al-Moghrabi, N, Al-Qasem, AJ, Aboussekhra, A (2011) Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women. International journal of oncology 39: pp. 129-135
113. Shan, J, Dsouza, SP, Bakhru, S, Al-Azwani, EK, Ascierto, ML, Sastry, KS, Bedri, S, Kizhakayil, D, Aigha, II, Malek, J (2013) TNRC9 downregulates BRCA1 expression and promotes breast cancer aggressiveness. Cancer research 73: pp. 2840-2849
114. Shan, J, Mahfoudh, W, Dsouza, SP, Hassen, E, Bouaouina, N, Abdelhak, S, Benhadjayed, A, Memmi, H, Mathew, RA, Aigha, II (2012) Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians. Breast cancer research and treatment 135: pp. 715-724
115. Alshatwi, AA, Shafi, G, Hasan, TN, Syed, NA, Al-Hazzani, AA, Alsaif, MA, Alsaif, AA (2012) Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PloS one 7: pp. e30049
116. George, GP, Gangwar, R, Mandal, RK, Sankhwar, SN, Mittal, RD (2011) Genetic variation in microRNA genes and prostate cancer risk in North Indian population. Molecular biology reports 38: pp. 1609-1615
117. Li, P, Yan, H, Zhang, H, Yu, L, Wang, Z, Zhai, Y, Xia, X, Zhang, J, Zhang, Y, Ma, F (2014) A Functional Polymorphism in MIR196A2 Is Associated with Risk and Progression of Nasopharyngeal Carcinoma in the Chinese Population. Genetic testing and molecular biomarkers 18: pp. 149-155
118. Hong, YS, Kang, HJ, Kwak, JY, Park, BL, You, CH, Kim, YM, Kim, H (2011) Association between microRNA196a2 rs11614913 genotypes and the risk of non-small cell lung cancer in Korean population. Journal of preventive medicine and public health = Yebang Uihakhoe chi 44: pp. 125-130
119. Catucci, I, Yang, R, Verderio, P, Pizzamiglio, S, Heesen, L, Hemminki, K, Sutter, C, Wappenschmidt, B, Dick, M, Arnold, N (2010) Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Human mutation 31: pp. E1052-1057
120. Issa, AM (2002) Ethical perspectives on pharmacogenomic profiling in the drug development process. Nature reviews Drug discovery 1: pp. 300-308
121. Evans, WE, McLeod, HL (2003) Pharmacogenomics--drug disposition, drug targets, and side effects. The New England journal of medicine 348: pp. 538-549
122. Harrison, N (2012) Report on the pharmacogenomics and personalized medicine 2011 conference: part 1. Pharmacogenomics 13: pp. 141-145
123. Wilke, RA, Lin, DW, Roden, DM, Watkins, PB, Flockhart, D, Zineh, I, Giacomini, KM, Krauss, RM (2007) Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nature reviews Drug discovery 6: pp. 904-916
124. Kalow, W (2006) Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine. The pharmacogenomics journal 6: pp. 162-165
125. Pirmohamed, M, Park, BK (2001) Genetic susceptibility to adverse drug reactions. Trends in pharmacological sciences 22: pp. 298-305
126. Need, AC, Motulsky, AG, Goldstein, DB (2005) Priorities and standards in pharmacogenetic research. Nature genetics 37: pp. 671-681
127. Severino, G, Del Zompo, M (2004) Adverse drug reactions: role of pharmacogenomics. Pharmacological research : the official journal of the Italian Pharmacological Society 49: pp. 363-373
128. Giacomini, KM, Krauss, RM, Roden, DM, Eichelbaum, M, Hayden, MR, Nakamura, Y (2007) When good drugs go bad. Nature 446: pp. 975-977
129. Nelson, DR, Kamataki, T, Waxman, DJ, Guengerich, FP, Estabrook, RW, Feyereisen, R, Gonzalez, FJ, Coon, MJ, Gunsalus, IC, Gotoh, O (1993) The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA and cell biology 12: pp. 1-51
130. Nebert, DW, Russell, DW (2002) Clinical importance of the cytochromes P450. Lancet 360: pp. 1155-1162
131. Nelson, DR, Zeldin, DC, Hoffman, SM, Maltais, LJ, Wain, HM, Nebert, DW (2004) Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14: pp. 1-18
132. Danielson, PB (2002) The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Current drug metabolism 3: pp. 561-597
133. Fisher, CD, Lickteig, AJ, Augustine, LM, Ranger-Moore, J, Jackson, JP, Ferguson, SS, Cherrington, NJ (2009) Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease. Drug metabolism and disposition: the biological fate of chemicals 37: pp. 2087-2094
134. Bains RK: plus-plus">African variation at Cytochrome P450 genes: Evolutionary aspects and the implications for the treatment of infectious diseases. / Evolution, medicine, and public health 2013, (1)plus-plus">:118鈥?34.
135. Frye, RF, Zgheib, NK, Matzke, GR, Chaves-Gnecco, D, Rabinovitz, M, Shaikh, OS, Branch, RA (2006) Liver disease selectively modulates cytochrome P450--mediated metabolism. Clinical pharmacology and therapeutics 80: pp. 235-245
136. Fleeman, N, Dundar, Y, Dickson, R, Jorgensen, A, Pushpakom, S, McLeod, C, Pirmohamed, M, Walley, T (2011) Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses. The pharmacogenomics journal 11: pp. 1-14
137. Cai, WM, Chen, B, Zhang, WX (2007) Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population. Clinical pharmacology and therapeutics 81: pp. 95-98
138. Gasche, Y, Daali, Y, Fathi, M, Chiappe, A, Cottini, S, Dayer, P, Desmeules, J (2004) Codeine intoxication associated with ultrarapid CYP2D6 metabolism. The New England journal of medicine 351: pp. 2827-2831
139. Kirchheiner, J, Roots, I, Goldammer, M, Rosenkranz, B, Brockmoller, J (2005) Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance. Clinical pharmacokinetics 44: pp. 1209-1225
140. Holstein, A, Beil, W, Kovacs, P (2012) CYP2C metabolism of oral antidiabetic drugs--impact on pharmacokinetics, drug interactions and pharmacogenetic aspects. Expert opinion on drug metabolism & toxicology 8: pp. 1549-1563
141. Mirghani, RA, Chowdhary, G, Elghazali, G (2011) Distribution of the major cytochrome P450 (CYP) 2C9 genetic variants in a Saudi population. Basic & clinical pharmacology & toxicology 109: pp. 111-114
142. Dai, DP, Wang, SH, Geng, PW, Hu, GX, Cai, JP (2013) In Vitro Assessment of 36 CYP2C9 Allelic Isoforms found in the Chinese Population on the Metabolism of Glimepiride. Basic & clinical pharmacology & toxicology.
143. Pirmohamed, M, Burnside, G, Eriksson, N, Jorgensen, AL, Toh, CH, Nicholson, T, Kesteven, P, Christersson, C, Wahlstrom, B, Stafberg, C (2013) A randomized trial of genotype-guided dosing of warfarin. The New England journal of medicine 369: pp. 2294-2303
144. Zhang, X, Li, L, Ding, X, Kaminsky, LS (2011) Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose. Drug metabolism and disposition: the biological fate of chemicals 39: pp. 1433-1439
145. Tanira, MO, Al-Mukhaini, MK, Al-Hinai, AT, Al Balushi, KA, Ahmed, IS (2007) Frequency of CYP2C9 genotypes among Omani patients receiving warfarin and its correlation with warfarin dose. Community genetics 10: pp. 32-37
146. Alzahrani, AM, Ragia, G, Hanieh, H, Manolopoulos, VG (2013) Genotyping of CYP2C9 and VKORC1 in the Arabic population of Al-Ahsa, Saudi Arabia. BioMed research international.
147. Hamdy, SI, Hiratsuka, M, Narahara, K, El-Enany, M, Moursi, N, Ahmed, MS, Mizugaki, M (2002) Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population. British journal of clinical pharmacology 53: pp. 596-603
148. Djaffar-Jureidini, I, Chamseddine, N, Keleshian, S, Naoufal, R, Zahed, L, Hakime, N (2011) Pharmacogenetics of coumarin dosing: prevalence of CYP2C9 and VKORC1 polymorphisms in the Lebanese population. Genetic testing and molecular biomarkers 15: pp. 827-830
149. Saour, JN, Shereen, AW, Saour, BJ, Mammo, LA (2011) CYP2C9 polymorphism studies in the Saudi population. Saudi medical journal 32: pp. 347-352
150. Heller, T, Kirchheiner, J, Armstrong, VW, Luthe, H, Tzvetkov, M, Brockmoller, J, Oellerich, M (2006) AmpliChip CYP450 GeneChip: a new gene chip that allows rapid and accurate CYP2D6 genotyping. Therapeutic drug monitoring 28: pp. 673-677
151. Gardiner, SJ, Begg, EJ (2006) Pharmacogenetics, drug-metabolizing enzymes, and clinical practice. Pharmacological reviews 58: pp. 521-590
152. Seip, RL, Duconge, J, Ruano, G (2010) Implementing genotype-guided antithrombotic therapy. Future cardiology 6: pp. 409-424
153. [p://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm" class="a-plus-plus">http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm]
154. Mohamed, S, Syed, BA (2013) Commercial prospects for genomic sequencing technologies. Nature reviews Drug discovery 12: pp. 341-342
155. DeFrancesco, L (2012) Life Technologies promises $1,000 genome. Nature biotechnology 30: pp. 126
156. Moore, CB, Wallace, JR, Frase, AT, Pendergrass, SA, Ritchie, MD (2013) BioBin: a bioinformatics tool for automating the binning of rare variants using publicly available biological knowledge. BMC medical genomics 6: pp. S6
157. Moore, CB, Wallace, JR, Frase, AT, Pendergrass, SA, Ritchie, MD (2013) Using BioBin to explore rare variant population stratification. Pacific Symposium on Biocomputing Pacific Symposium on Biocomputing. pp. 332-343
158. Gerasch, A, Faber, D, Kuntzer, J, Niermann, P, Kohlbacher, O, Lenhof, HP, Kaufmann, M (2014) BiNA: A Visual Analytics Tool for Biological Network Data. PloS one 9: pp. e87397
159. Frueh, FW, Gurwitz, D (2004) From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community. Pharmacogenomics 5: pp. 571-579
160. Buchanan, JA, Carson, AR, Chitayat, D, Malkin, D, Meyn, MS, Ray, PN, Shuman, C, Weksberg, R, Scherer, SW (2009) The cycle of genome-directed medicine. Genome medicine 1: pp. 16
161. Ibrahim, NK, Al-Bar, H, Al-Fakeeh, A, Al Ahmadi, J, Qadi, M, Al-Bar, A, Milaat, W (2011) An educational program about premarital screening for unmarried female students in King Abdul-Aziz University, Jeddah. Journal of infection and public health 4: pp. 30-40
162. Ali-Khan, SE, Daar, AS, Shuman, C, Ray, PN, Scherer, SW (2009) Whole genome scanning: resolving clinical diagnosis and management amidst complex data. Pediatric research 66: pp. 357-363
163. McBride, MS (2002) Bioinformatics and Intellectual Property Protection. Berkeley technology law journal 17: pp. 1331-1334
164. Manwar Hussain, MR, Khan, A, Ali Mohamoud, HS (2014) From Genes to Health - Challenges and Opportunities. Frontiers in pediatrics 2: pp. 12
165. D'Souza, S (2004) Gene meets machine: intellectual property issues in bioinformatics. Health Law Review 12: pp. 34-43
166. Kesh, S, Raghupathi, W (2004) Critical issues in bioinformatics and computing. Perspectives in health information management / AHIMA, American Health Information Management Association 1: pp. 9
167. Ogbogu, U, Burningham, S, Ollenberger, A, Calder, K, Du, L, El Emam, K, Hyde-Lay, R, Isasi, R, Joly, Y, Kerr, I (2014) Policy recommendations for addressing privacy challenges associated with cell-based research and interventions. BMC medical ethics 15: pp. 7
168. Vahakangas, K (2013) Research ethics in the post-genomic era. Environmental and Molecular Mutagenesis 54: pp. 599-610
169. Bowdin, S, Ray, P, Cohn, RD, Meyn, MS (2014) The Genome Clinic: A Multidisciplinary Approach to Assessing the Opportunities and Challenges of Integrating Genomic Analysis Into Clinical Care. Human mutation.
170. Niazi, MA, al-Mazyad, AS, al-Husain, MA, al-Mofada, SM, al-Zamil, FA, Khashoggi, TY, al-Eissa, YA (1995) Down's syndrome in Saudi Arabia: incidence and cytogenetics. Human heredity 45: pp. 65-69
171. Refat, MY, Al-Moghanem, M, McDonald, P, Reyes, L (1995) Major birth defects at King Fahd Hofuf Hospital: Prevalence, risk factors and outcome. Annals of Saudi medicine 15: pp. 339-343
172. Almawazini, AM, Al-Ghamdi, AS (2011) Congenital heart disease in south-west Saudi Arabia. Saudi medical journal 32: pp. 195-196
173. Alabdulgader, AA (2001) Congenital heart disease in 740 subjects: epidemiological aspects. Annals of tropical paediatrics 21: pp. 111-118
174. Nazer, H, Riff, E, Sakati, N, Mathew, R, Majeed-Saidan, MA, Harfi, H (1989) Cystic fibrosis in Saudi Arabia. European journal of pediatrics 148: pp. 330-332
175. Banjar, H (2003) Morbidity and mortality data of cystic fibrosis patients. Saudi medical journal 24: pp. 730-735
176. Zakzouk, SM, Fadle, KA, al Anazy, FH (1995) Familial hereditary progressive sensorineural hearing loss among Saudi population. International journal of pediatric otorhinolaryngology 32: pp. 247-255
177. JAMAL, TS, DAGHISTANI, KJ, ZAKZOUK, SS (2002) Impact of Consanguinity on Childhood Hearing Impairment in a Saudi Population. J KAU: Med Sci 10: pp. 23-31
178. Al-Qahtani, MH, Baghlab, I, Chaudhary, AG, Abuzenadah, AM, Bamanie, A, Daghistani, KJ, Safieh, M, Fida, L, Dallol, A (2010) Spectrum of GJB2 mutations in a cohort of nonsyndromic hearing loss cases from the Kingdom of Saudi Arabia. Genetic testing and molecular biomarkers 14: pp. 79-83
179. Tabbara, KF, Badr, IA (1985) Changing pattern of childhood blindness in Saudi Arabia. The British journal of ophthalmology 69: pp. 312-315
180. Tabbara, KF, El-Sheikh, HF, Shawaf, SS (2005) Pattern of childhood blindness at a referral center in Saudi Arabia. Annals of Saudi medicine 25: pp. 18-21
181. Al-Nozha, MM, Al-Maatouq, MA, Al-Mazrou, YY, Al-Harthi, SS, Arafah, MR, Khalil, MZ, Khan, NB, Al-Khadra, A, Al-Marzouki, K, Nouh, MS (2004) Diabetes mellitus in Saudi Arabia. Saudi medical journal 25: pp. 1603-1610
182. El-Hazmi, MA, Warsy, AS, Al-Swailem, AR, Al-Swailem, AM, Sulaimani, R, Al-Meshari, AA (1996) Diabetes mellitus and impaired glucose tolerance in Saudi Arabia. Annals of Saudi medicine 16: pp. 381-385
183. Alhamdan, NA, Almazrou, YY, Alswaidi, FM, Choudhry, AJ (2007) Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genetics in medicine : official journal of the American College of Medical Genetics 9: pp. 372-377
184. Akhtar, MS, Qaw, F, Borgio, JF, Albuali, W, Suliman, A, Nasserullah, Z, Al-Jarrash, S, Al-Ali, A (2013) Spectrum of alpha-thalassemia mutations in transfusion-dependent beta-thalassemia patients from the Eastern Province of Saudi Arabia. Hemoglobin 37: pp. 65-73
185. Memish, ZA, Owaidah, TM, Saeedi, MY (2011) Marked regional variations in the prevalence of sickle cell disease and beta-thalassemia in Saudi Arabia: findings from the premarital screening and genetic counseling program. Journal of epidemiology and global health 1: pp. 61-68
186. Abuzenadah, AM, Hussein, IM, Damanhouri, GA, FM, AS, Gari, MA, Chaudhary, AG, Zaher, GF, Al-Attas, A, Al-Qahtani, MH (2011) Molecular basis of beta-thalassemia in the western province of Saudi Arabia: identification of rare beta-thalassemia mutations. Hemoglobin 35: pp. 346-357
187. El Mouzan, MI, Al Awamy, BH, Al Torki, MT (1990) Clinical features of sickle cell disease in eastern Saudi Arab children. The American journal of pediatric hematology/oncology 12: pp. 51-55
188. Nasserullah, Z, Alshammari, A, Abbas, MA, Abu-Khamseen, Y, Qadri, M, Jafer, SA, Wabel, MA (2003) Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency. Annals of Saudi medicine 23: pp. 354-357
189. Al-Qurashi, MM, El-Mouzan, MI, Al-Herbish, AS, Al-Salloum, AA, Al-Omar, AA (2008) The prevalence of sickle cell disease in Saudi children and adolescents. A community-based survey. Saudi medical journal 29: pp. 1480-1483
190. El-Hazmi, MA, Al-Hazmi, AM, Warsy, AS (2011) Sickle cell disease in Middle East Arab countries. The Indian journal of medical research 134: pp. 597-610
191. Muzaffer, MA (2005) Neonatal screening of glucose-6-phosphate dehydrogenase deficiency in Yanbu, Saudi Arabia. Journal of medical screening 12: pp. 170-171
192. Warsy, AS, El-Hazmi, MA (2001) G6PD deficiency, distribution and variants in Saudi Arabia: an overview. Annals of Saudi medicine 21: pp. 174-177 - 刊物主题：Human Genetics; Microarrays;
- 出版者：BioMed Central
- ISSN：1755-8794
文摘
The biomedical research sector in Saudi Arabia has recently received special attention from the government, which is currently supporting research aimed at improving the understanding and treatment of common diseases afflicting Saudi Arabian society. To build capacity for research and training, a number of centres of excellence were established in different areas of the country. Among these, is the Centre of Excellence in Genomic Medicine Research (CEGMR) at King Abdulaziz University, Jeddah, with its internationally ranked and highly productive team performing translational research in the area of individualized medicine. Here, we present a panorama of the recent trends in different areas of biomedical research in Saudi Arabia drawing from our vision of where genomics will have maximal impact in the Kingdom of Saudi Arabia. We describe advances in a number of research areas including; congenital malformations, infertility, consanguinity and pre-implantation genetic diagnosis, cancer and genomic classifications in Saudi Arabia, epigenetic explanations of idiopathic disease, and pharmacogenomics and personalized medicine. We conclude that CEGMR will continue to play a pivotal role in advances in the field of genomics and research in this area is facing a number of challenges including generating high quality control data from Saudi population and policies for using these data need to comply with the international set up.